Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
  • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
  • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
  • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
  • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
  • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/20—Pills, tablets, discs, rods
  • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P3/00—Drugs for disorders of the metabolism
  • A61P3/06—Antihyperlipidemics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/20—Pills, tablets, discs, rods
  • A61K9/2004—Excipients; Inactive ingredients
  • A61K9/2022—Organic macromolecular compounds
  • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
  • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

• Health & Medical Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Veterinary Medicine (AREA)
• Life Sciences & Earth Sciences (AREA)
• Public Health (AREA)
• Chemical & Material Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Medicinal Chemistry (AREA)
• Epidemiology (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Emergency Medicine (AREA)
• Hematology (AREA)
• General Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Obesity (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Diabetes (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Medicinal Preparation (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medical Preparation Storing Or Oral Administration Devices (AREA)
• Saccharide Compounds (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=32843093

Family Applications (1)

Country Status (20)

Families Citing this family (7)

Family Cites Families (12)

• 2003
  • 2003-02-28 FR FR0302520A patent/FR2851734B1/fr not_active Expired - Fee Related
• 2004
  • 2004-02-27 AT AT04715360T patent/ATE439125T1/de not_active IP Right Cessation
  • 2004-02-27 MX MXPA05009113A patent/MXPA05009113A/es active IP Right Grant
  • 2004-02-27 NZ NZ542039A patent/NZ542039A/en unknown
  • 2004-02-27 WO PCT/FR2004/050090 patent/WO2004078108A2/fr not_active Application Discontinuation
  • 2004-02-27 US US10/546,999 patent/US20060177499A1/en not_active Abandoned
  • 2004-02-27 AU AU2004216869A patent/AU2004216869B2/en not_active Ceased
  • 2004-02-27 JP JP2006505844A patent/JP2006520770A/ja active Pending
  • 2004-02-27 DE DE602004022515T patent/DE602004022515D1/de not_active Expired - Lifetime
  • 2004-02-27 RU RU2005130155/15A patent/RU2362547C2/ru not_active IP Right Cessation
  • 2004-02-27 EP EP04715360A patent/EP1601346B1/de not_active Expired - Lifetime
  • 2004-02-27 CN CNB2004800113413A patent/CN100479808C/zh not_active Expired - Fee Related
  • 2004-02-27 BR BRPI0407850-0A patent/BRPI0407850A/pt not_active IP Right Cessation
  • 2004-02-27 PL PL378106A patent/PL378106A1/pl not_active Application Discontinuation
  • 2004-02-27 CA CA2517429A patent/CA2517429C/fr not_active Expired - Fee Related
• 2005
  • 2005-08-25 IL IL170507A patent/IL170507A/en not_active IP Right Cessation
  • 2005-08-26 TN TNP2005000203A patent/TNSN05203A1/fr unknown
  • 2005-08-26 MA MA28458A patent/MA27662A1/fr unknown
  • 2005-08-31 ZA ZA200506992A patent/ZA200506992B/xx unknown
  • 2005-09-23 NO NO20054417A patent/NO20054417L/no not_active Application Discontinuation

Also Published As

Similar Documents